Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

DW Haas, A Kwara, DM Richardson… - Journal of …, 2014 - academic.oup.com
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …
被引用次数：61 相关文章

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

DW Haas, A Kwara, DM Richardson… - The Journal of …, 2014 - europepmc.org
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …
[PDF] researchgate.net

[PDF][PDF] Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

DW Haas, A Kwara, DM Richardson, P Baker… - 2014 - researchgate.net
Objectives: Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516GT and 983TC define efavirenz slow metabolizer genotypes. To identify genetic …

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

DW Haas, A Kwara, DM Richardson, P Baker… - 2014 - cabidigitallibrary.org
Objectives: Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …
[HTML] nih.gov

[HTML][HTML] Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

DW Haas, A Kwara, DM Richardson… - Journal of …, 2014 - ncbi.nlm.nih.gov
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

DW Haas, A Kwara, DM Richardson, P Baker… - Journal of …, 2014 - hero.epa.gov
Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms 516Gâ†'T
and 983Tâ†'C define efavirenz slow metabolizer genotypes. To identify genetic predictors of …

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

DW Haas, A Kwara, DM Richardson… - Journal of …, 2014 - search.ebscohost.com
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

DW Haas, A Kwara, DM Richardson… - The Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

DW Haas, A Kwara, DM Richardson… - The Journal of …, 2014 - europepmc.org
Objectives Efavirenz is widely prescribed for HIV-1 infection, and CYP2B6 polymorphisms
516G→ T and 983T→ C define efavirenz slow metabolizer genotypes. To identify genetic …